Animalcare Group (ANCR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

291.00p
   
  • Change Today:
      11.00p
  • 52 Week High: 301.00p
  • 52 Week Low: 209.00p
  • Currency: UK Pounds
  • Shares Issued: 68.99m
  • Volume: 37,801
  • Market Cap: £200.76m
  • Beta: 0.02

Deal with Barclays    Trade now with Barclays Stockbrokers

Animalcare posts flat revenues as supply chain challenges dent sales

By Iain Gilbert

Date: Tuesday 23 Jul 2019

LONDON (ShareCast) - (Sharecast News) - Animal health business Animalcare posted flat revenues for the first half as sales were impacted by supply chain issues at a third-party manufacturer.
Revenues were steady at £36.1m, but the company did manage to record a 0.9% improvement on a constant currency basis.

Animalcare said this small improvement was "noteworthy", given previously reported supply challenges which impacted sales by £1.1m during the half.

"We are on track to resolve the supply issues during the current financial year which is anticipated to be reflected in sales during the second half," it said.

The company, which committed to reducing net debt and improving cash conversion, saw net debt come to £21m, down from the £23.6m on 31 December.

Chief executive Jenny Winter said: "We have a clear strategy to become a leading international veterinary pharmaceutical business and we have made good progress towards this goal during the first half of 2019.

"I am pleased that the growth platform that we have been focused on building is coming to fruition and I look forward to updating the market further on our progress."

At 1050 BST, Animalcare shares were up 3.85% to 162p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

ANCR Market Data

Currency UK Pounds
Share Price 291.00p
Change Today 11.00p
% Change 3.93 %
52 Week High 301.00p
52 Week Low 209.00p
Volume 37,801
Shares Issued 68.99m
Market Cap £200.76m
Beta 0.02

ANCR Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.01% below the market average94.01% below the market average94.01% below the market average94.01% below the market average94.01% below the market average
91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average
Price Trend
80.24% above the market average80.24% above the market average80.24% above the market average80.24% above the market average80.24% above the market average
86.96% above the sector average86.96% above the sector average86.96% above the sector average86.96% above the sector average86.96% above the sector average
Income
89.52% below the market average89.52% below the market average89.52% below the market average89.52% below the market average89.52% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Growth
10.29% above the market average10.29% above the market average10.29% above the market average10.29% above the market average10.29% above the market average
18.75% below the sector average18.75% below the sector average18.75% below the sector average18.75% below the sector average18.75% below the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

ANCR Dividends

  Latest Previous
  Final Interim
Ex-Div 19-Jun-25 17-Oct-24
Paid 18-Jul-25 15-Nov-24
Amount 3.00p 2.00p

Trades for 18-Jul-2025

Time Volume / Share Price
14:38 11,631 @ 286.75p
15:49 3 @ 294.75p
15:37 250 @ 292.00p
15:34 1,750 @ 287.30p
15:25 1,000 @ 290.00p

ANCR Key Personnel

CFO Chris Brewster
CEO Jenny Winter

Top of Page